| Dr Paul D Ross, MD | |
|
3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766-1098 | |
| (808) 245-1561 | |
| (808) 246-1362 |
| Full Name | Dr Paul D Ross |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3-3420 Kuhio Hwy, Lihue, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760552913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD-7556 (Hawaii) | Primary |
| Entity Name | Kauai Medical Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376596643 PECOS PAC ID: 5092628479 Enrollment ID: O20031111000540 |
News Archive
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.
Nearly half of all children in the United States are exposed to at least one social or family experience that can lead to traumatic stress and impact their healthy development - be it having their parents divorce, a parent die or living with someone who abuses alcohol or drugs - increasing the risk of negative long-term health consequences or of falling behind in school, suggests new research led by the Johns Hopkins Bloomberg School of Public Health.
Genetic testing holds great promise for the future. Information generated by genetic testing may provide information that leads to new treatments for common diseases such as heart disease and diabetes.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals has submitted a Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency in the United Kingdom for Iluvien (fluocinolone acetonide intravitreal insert).
The ongoing coronavirus pandemic (COVID-19) has claimed more than 4.1 million lives worldwide. This pandemic is caused by a novel single-stranded RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first reported in 2019 in Wuhan, China. The rapid spread of this virus is attributed to its high infectiousness and its ability to escape and counteract host immune responses, e.g., autophagy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul D Ross, MD 3-3420 Kuhio Highway, Suite B, Lihue, HI 96766-1098 Ph: (808) 245-1561 | Dr Paul D Ross, MD 3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766-1098 Ph: (808) 245-1561 |
News Archive
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.
Nearly half of all children in the United States are exposed to at least one social or family experience that can lead to traumatic stress and impact their healthy development - be it having their parents divorce, a parent die or living with someone who abuses alcohol or drugs - increasing the risk of negative long-term health consequences or of falling behind in school, suggests new research led by the Johns Hopkins Bloomberg School of Public Health.
Genetic testing holds great promise for the future. Information generated by genetic testing may provide information that leads to new treatments for common diseases such as heart disease and diabetes.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals has submitted a Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency in the United Kingdom for Iluvien (fluocinolone acetonide intravitreal insert).
The ongoing coronavirus pandemic (COVID-19) has claimed more than 4.1 million lives worldwide. This pandemic is caused by a novel single-stranded RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first reported in 2019 in Wuhan, China. The rapid spread of this virus is attributed to its high infectiousness and its ability to escape and counteract host immune responses, e.g., autophagy.
› Verified 4 days ago
Carl Yu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766 Phone: 808-245-1561 Fax: 808-246-1362 | |
Dr. Terence John Carolan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2978 Haleko Rd, Lihue, HI 96766 Phone: 808-245-8566 Fax: 808-246-4989 | |
Dr. Geri Q.l. Young, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766 Phone: 808-245-1561 Fax: 808-246-1362 | |
Dr. Robert D. Wotring Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766 Phone: 808-245-1561 Fax: 808-246-1362 | |
Dr. Brigitte A Carreau, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3-3420 Kuhio Hwy, Suite B, Lihue, HI 96766 Phone: 808-245-1500 |